Skip to main content
. 2011 Dec 1;12(11):957–965. doi: 10.4161/cbt.12.11.18134

Table 1. Body weight change (g), tissue mass (mg) and plasma metabolites for late-stage cachexia study.

 
No tumor
Tumor
Effect p value
  PBS RGZ   PBS RGZ RGZ-PF   Treatment Tumor Treatment x Tumor
Body weight change
3.0 ± 0.3
3.4 ± 0.3
 
−2.9 ± 0.4
−1.0 ± 0.6*
−3.3 ± 0.3
 
0.005
< 0.001
0.064
Quadriceps muscle
372 ± 19
347 ± 22
 
281 ± 19
271 ± 15
221 ± 14*
 
0.342
< 0.001
0.693
Tibialis Anterior muscle
96 ± 4
103 ± 4
 
68 ± 4
72 ± 5
65 ± 3
 
0.184
< 0.001
0.778
Gastrocnemius muscle
223 ± 9
227 ± 7
 
160 ± 8
177 ± 10
156 ± 6
 
0.226
< 0.001
0.421
Epidydimal adipose
664 ± 40
862 ± 31
 
91 ± 23
249 ± 55*
133 ± 21
 
< 0.001
< 0.001
0.636
Inguinal adipose
513 ± 28
580 ± 53
 
35 ± 16
179 ± 51*
64 ± 17
 
0.014
< 0.001
0.355
Brown adipose
132 ± 6
176 ± 9
 
40 ± 7
87 ± 11**
78 ± 5***
 
< 0.001
< 0.001
0.878
Tumor
 
 
 
1648 ± 98
1754 ± 87
1846 ± 102
 
 
 
 
Fasting glucose (mmol/L)
8.0 ± 0.3
7.5 ± 0.3
 
4.4 ± 0.8
3.6 ± 0.5
3.3 ± 0.4
 
0.174
< 0.001
0.804
Insulin-stimulated glucose change (mmol/L)
−1.6 ± 0.3
−1.9 ± 0.4
 
0.2 ± 0.2
0.5 ± 0.2
0.3 ± 0.2
 
0.920
< 0.001
0.398
Adiponectin (ng/ml)
9202 ± 592
19342 ± 490
 
3384 ± 274
6431 ± 632**
6803 ± 574**
 
< 0.001
< 0.001
< 0.001
IL-6 (pg/ml)
2 ± 1
5 ± 3
 
274 ± 101
134 ± 29
127 ± 31
 
0.087
< 0.001
0.075
NEFA (mEq/L) 0.33 ± 0.02 0.26 ± 0.02   0.25 ± 0.06 0.36 ± 0.10 0.35 ± 0.10   0.698 0.898 0.128

Mice were inoculated with 1x106 colon-26 adenocarcinoma cells (+) or vehicle (-) on day 0, and treated daily with IP injections of PBS or RGZ. Some RGZ(+) mice were pair-fed to the PBS(+) group. Mice were sacrificed when there was ~30% difference in body weight between the PBS(-) and PBS(+) groups. Two-way ANOVA was done to analyze tumor, treatment and tumor x treatment effects between the PBS(-), RGZ(-), PBS(+) and RGZ(+) groups. Two-sample t-tests with the Bonferroni correction factor were done to determine differences between the RGZ(+) and RGZ-PF(+) groups compared with the PBS(+) group. n = 13–15 mice/group, *p < 0.05, **p < 0.01, ***p < 0.001.